Total trials
53
Active
0
Phase 3
20
Total enrollment
120,148
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Influenza26
- Influenza, Human23
- Virus Diseases4
- Infections3
- Respiratory Tract Infections3
- Human2
- Pregnancy2
- Birth Defect2
Frequently asked questions about Seqirus
- How many clinical trials does Seqirus have on ClinicalTrials.gov?
- Seqirus is listed as the lead sponsor on 53 clinical trials in ClinicalTrials.gov, 0 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Seqirus's trials are in Phase 3?
- 20 of Seqirus's trials are in Phase 3.
- What therapeutic areas does Seqirus focus on?
- Seqirus's most-studied conditions on ClinicalTrials.gov are Influenza, Influenza, Human, Virus Diseases, Infections, Respiratory Tract Infections.